Trial Outcomes & Findings for Effect of TrueTear Corneal Surface Imaging (NCT NCT03637348)
NCT ID: NCT03637348
Last Updated: 2020-08-11
Results Overview
Surface asymmetry index (SAI) is an index that indicates an average value of the corneal power differences between the points spatially located at 180° from 128 equidistant meridians. A radially symmetrical surface has a value of zero, and this value increases as the degree of asymmetry is greater. Higher values are worse, but there is no set maximum value and no unit of measure.
COMPLETED
NA
45 participants
Change from baseline SAI at 5-10 minutes after using the TrueTear device.
2020-08-11
Participant Flow
Participant milestones
| Measure |
TrueTear
Use of TrueTear device to stimulate tear production
TrueTear: Use of TrueTear neurostimulator
|
|---|---|
|
Overall Study
STARTED
|
45
|
|
Overall Study
COMPLETED
|
45
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effect of TrueTear Corneal Surface Imaging
Baseline characteristics by cohort
| Measure |
TrueTear
n=45 Participants
Use of TrueTear device to stimulate tear production
TrueTear: Ues of TrueTear neurostimulator
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
35 Participants
n=5 Participants
|
|
Age, Continuous
|
69 years
STANDARD_DEVIATION 10 • n=5 Participants
|
|
Sex: Female, Male
Female
|
27 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
45 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
45 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Change from baseline SAI at 5-10 minutes after using the TrueTear device.Surface asymmetry index (SAI) is an index that indicates an average value of the corneal power differences between the points spatially located at 180° from 128 equidistant meridians. A radially symmetrical surface has a value of zero, and this value increases as the degree of asymmetry is greater. Higher values are worse, but there is no set maximum value and no unit of measure.
Outcome measures
| Measure |
TrueTear
n=45 Participants
Use of TrueTear device to stimulate tear production
TrueTear: Ues of TrueTear neurostimulator
|
|---|---|
|
Surface Asymmetry Index (SAI) Assessed With Corneal Topography
|
0.21 unitless
Standard Deviation 0.34
|
SECONDARY outcome
Timeframe: Change from baseline SRI at 5-10 minutes after using the TrueTear device.Surface Regularity index (SRI) is a local descriptor of surface regularity in a central 4.5 mm diameter area of the cornea. It correlates well with the value of visual acuity (p = 0.80, P \<0.001), assuming the cornea is the only limiting factor for vision. A normal cornea presents SRI values below 0.56 (the SRI would be 0 in a perfectly regular cornea). SRI values increase with increasing irregularity of the corneal surface. Higher values are worse, but there is no set maximum value and no unit of measure.
Outcome measures
| Measure |
TrueTear
n=45 Participants
Use of TrueTear device to stimulate tear production
TrueTear: Ues of TrueTear neurostimulator
|
|---|---|
|
Surface Regularity Index (SRI) Assessed With Corneal Topography
|
0.1 unitless
Standard Deviation 0.3
|
Adverse Events
TrueTear
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Marianne Price, PhD
Cornea Research Foundation of America
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place